BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE - Generic Drug Details
✉ Email this page to a colleague
Summary for BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE
US Patents: | 0 |
Tradenames: | 1 |
Applicants: | 1 |
NDAs: | 1 |
Drug Master File Entries: | 22 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 3 |
DailyMed Link: | BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE at DailyMed |
Recent Clinical Trials for BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
American University of Beirut Medical Center | Phase 4 |
The University of Texas Health Science Center, Houston | Phase 4 |
Forest Laboratories | Phase 3 |
See all BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE clinical trials